Compare Incyte Corporation (INCY) vs Trade Desk Inc (TTD) Price & Performance

Incyte (INCY) trades at $112.75, down 0.61% on the day, with a bearish technical signal despite strong fundamentals. The company reported robust 2025 results with $5.14B revenue and $1.29B net income, showing significant margin expansion. Recent FDA approval for Atebrioz and pipeline progress support growth prospects beyond JAKAFI's 2029 exclusivity loss. Analyst consensus is bullish with a $132.43 price target, though technical indicators show selling pressure near key resistance.

Outlook remains positive driven by pipeline diversification and operational leverage, but near-term technical weakness and reliance on JAKAFI transition pose risks. The stock offers value with a 14.36 P/E ratio and strong profitability metrics, though investors should monitor execution on the $4B non-JAKAFI sales target and quarterly earnings consistency.

The Trade Desk (TTD) trades at $12.34, up 2.07% today but remains down significantly from recent highs. Technical indicators show a bearish trend with mixed momentum signals. Fundamentally, the company maintains strong profitability with 76.87% gross margins and 15.44% ROE, though revenue growth has slowed to 3% in 2026. Recent news highlights competitive pressures from Amazon and Alphabet while the company navigates workforce reductions and slower CTV growth.

Investment outlook remains cautious with analyst consensus at $14.72 target price representing 19% upside potential. Key opportunities include TTD's dominant position in programmatic advertising and healthy cash flow generation. Primary risks involve intensifying competition from tech giants, slowing revenue growth, and execution challenges during restructuring. The stock presents a value opportunity for patient investors if competitive pressures ease.